ctDNA as a prognostic biomarker in resectable CLM: Systematic review and meta-analysis

Cell-free circulating tumor DNA (ctDNA) is synthesized by tumor cells, including metastatic tumors, and circulates in the bloodstream. Evidence suggests that ctDNA is a potential predictive and prognostic biomarker for colorectal cancer (CRC), but its predictive efficacy in detecting CRC liver metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Da, Zhao, Penglai, Lu, Tingting, Ren, Jingyao, Zhu, Lihui, Han, Xiaoyong, Zhang, Guangming, Dong, Xiaohua, Ma, Haizhong, Yu, Miao, Cai, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224622/
https://www.ncbi.nlm.nih.gov/pubmed/37250841
http://dx.doi.org/10.1515/biol-2022-0615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224622/
https://www.ncbi.nlm.nih.gov/pubmed/37250841
http://dx.doi.org/10.1515/biol-2022-0615

Ejemplares similares